ACEI vs. ARBs

Attribute	ACEI	ARBs
Mechanism of action	Inhibit ACE enzyme to reduce angiotensin II production	Block angiotensin II receptors
Common side effects	Cough, hyperkalemia, angioedema	Dizziness, hyperkalemia, hypotension
Use in pregnancy	Avoid in 2nd and 3rd trimesters	Avoid in 2nd and 3rd trimesters
Renal protection	May slow progression of renal disease	May slow progression of renal disease

Introduction

ACE inhibitors (ACEI) and angiotensin II receptor blockers (ARBs) are two classes of medications commonly used to treat hypertension and other cardiovascular conditions. While both ACEI and ARBs are effective in lowering blood pressure, they work in slightly different ways and have unique attributes that may make one more suitable than the other for certain patients.

Mechanism of Action

ACE inhibitors work by blocking the enzyme angiotensin-converting enzyme (ACE), which is responsible for converting angiotensin I into angiotensin II. By inhibiting this enzyme, ACE inhibitors reduce the production of angiotensin II, a potent vasoconstrictor that causes blood vessels to narrow and blood pressure to increase. On the other hand, ARBs work by blocking the action of angiotensin II at the receptor level, preventing it from binding to its receptors and exerting its vasoconstrictive effects.

Side Effects

Both ACE inhibitors and ARBs are generally well-tolerated, but they can cause side effects in some patients. Common side effects of ACE inhibitors include a persistent dry cough, dizziness, and elevated potassium levels. In contrast, ARBs are less likely to cause a cough but may lead to dizziness, headache, and diarrhea. Both classes of medications can also cause hyperkalemia, a condition characterized by high levels of potassium in the blood.

Renal Protection

ACE inhibitors have been shown to provide renal protection in patients with diabetes and chronic kidney disease. By dilating the efferent arteriole in the kidney, ACE inhibitors can reduce intraglomerular pressure and slow the progression of kidney damage. ARBs, on the other hand, also offer renal protection by blocking the effects of angiotensin II on the kidneys. Studies have shown that both ACE inhibitors and ARBs can delay the onset of end-stage renal disease in high-risk patients.

Cardiovascular Benefits

Both ACE inhibitors and ARBs have been shown to provide cardiovascular benefits beyond their blood pressure-lowering effects. ACE inhibitors have been shown to reduce the risk of heart failure, myocardial infarction, and stroke in patients with hypertension and other cardiovascular conditions. Similarly, ARBs have been shown to reduce the risk of cardiovascular events in high-risk patients, including those with heart failure and left ventricular dysfunction.

Drug Interactions

ACE inhibitors and ARBs can interact with other medications, potentially leading to adverse effects or reduced efficacy. ACE inhibitors should not be used concomitantly with potassium-sparing diuretics or potassium supplements, as this can increase the risk of hyperkalemia. Similarly, ARBs should not be used with ACE inhibitors or aliskiren, as this can increase the risk of renal impairment, hypotension, and hyperkalemia.

Cost

Cost can be a significant factor when choosing between ACE inhibitors and ARBs. ACE inhibitors are generally available as generic medications and tend to be more affordable than ARBs. However, some patients may require ARBs due to intolerance or contraindications to ACE inhibitors, despite the higher cost. It is important to consider both the cost and the clinical benefits when selecting the most appropriate medication for an individual patient.

Conclusion

ACE inhibitors and ARBs are two classes of medications commonly used to treat hypertension and other cardiovascular conditions. While both ACE inhibitors and ARBs are effective in lowering blood pressure and providing cardiovascular benefits, they have unique attributes that may make one more suitable than the other for certain patients. It is important to consider factors such as mechanism of action, side effects, renal protection, cardiovascular benefits, drug interactions, and cost when selecting the most appropriate medication for an individual patient.